Algert Global LLC Celldex Therapeutics, Inc. Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
A detailed history of Algert Global LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 104,337 shares of CLDX stock, worth $2.04 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
104,337
Previous 54,983
89.76%
Holding current value
$2.04 Million
Previous $1.87 Million
41.09%
% of portfolio
0.06%
Previous 0.05%
Shares
17 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$99.1 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$91.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$76 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.5 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$69.6 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $915M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...